Search details
1.
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 22(1D): e240001, 2024 01.
Article
in English
| MEDLINE | ID: mdl-38244272
2.
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(1): 67-81, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36652935
3.
Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(12): 1281-1301, 2023 12.
Article
in English
| MEDLINE | ID: mdl-38081133
4.
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022.
J Natl Compr Canc Netw
; 20(1): 8-19, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34991075
5.
Effect of initial treatment on health-related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect® MM Registry.
Br J Haematol
; 193(1): 93-100, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33118614
6.
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 26(7): 1247-1256, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32165328
7.
Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysis.
Cancer
; 126(19): 4332-4340, 2020 10 01.
Article
in English
| MEDLINE | ID: mdl-32706404
8.
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 18(12): 1685-1717, 2020 12 02.
Article
in English
| MEDLINE | ID: mdl-33285522
9.
NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.
J Natl Compr Canc Netw
; 17(10): 1154-1165, 2019 10 01.
Article
in English
| MEDLINE | ID: mdl-31590151
10.
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018.
J Natl Compr Canc Netw
; 16(1): 11-20, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29295877
11.
Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(2): 230-269, 2017 02.
Article
in English
| MEDLINE | ID: mdl-28188192
12.
Guidelines for defining and implementing standard episode of care for hematopoietic stem cell transplantation within the context of clinical trials.
Biol Blood Marrow Transplant
; 21(4): 583-8, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25639771
13.
Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 21(11): 1863-1869, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26256941
14.
Real-World Utilization of Radiation Therapy in Multiple Myeloma: An Analysis of the Connect MM Registry.
Pract Radiat Oncol
; 14(2): e141-e149, 2024.
Article
in English
| MEDLINE | ID: mdl-37984714
15.
Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial.
Lancet Haematol
; 10(11): e890-e901, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37776872
16.
Effect of t (11;14) Abnormality on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect MM Registry.
Clin Lymphoma Myeloma Leuk
; 22(3): 149-157, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34588149
17.
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma.
J Clin Oncol
; 40(25): 2901-2912, 2022 09 01.
Article
in English
| MEDLINE | ID: mdl-34898239
18.
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review.
Biol Blood Marrow Transplant
; 17(1): 20-47.e30, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-20656046
19.
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials.
Leukemia
; 35(1): 18-30, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32778736
20.
Connect MM Registry as a national reference for United States multiple myeloma patients.
Cancer Med
; 9(1): 35-42, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31701679